DECOY THERAPEUTICS INC
DCOY · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $1.40
- Today’s Low
- $1.21
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.47
- Previous Close
- $1.43
- Volume
- 59.04K
- Market Cap
- $3.41M
- P/E Ratio
- --
- EPS
- $-934.88
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2450 HOLCOMBE BLVD, HOUSTON, TX, UNITED STATES, 77021
- Country
- US
- Listing Date
- 2015-01-29
- Fiscal Year End
- December
- Shares Outstanding
- 530K
- CIK
- 0001615219
- Website
- salariuspharma.com
Decoy Therapeutics Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing. The company is headquartered in Cambridge, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$2.63M
2026-03-31
$2.28M
2025-12-31
$517.7K
2025-09-30
$895.13K
Net Income
2026-06-30
-$2.37M
2026-03-31
-$2.22M
2025-12-31
-$8.97M
2025-09-30
-$873.46K
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-4.46
2026-03-31
$-4.18
2025-12-31
$43.10
2025-09-30
$-21.72
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$2.36M
2026-03-31
-$2.21M
2025-12-31
-$8.97M
2025-09-30
-$872.36K
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $2.63M | $2.28M | $517.7K | $895.13K |
| Net Income | -$2.37M | -$2.22M | -$8.97M | -$873.46K |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-4.46 | $-4.18 | $43.10 | $-21.72 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$2.36M | -$2.21M | -$8.97M | -$872.36K |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.